Pharmacotherapy in pediatric sleep disorders

Shelly K Weiss1, Andrea Garbutt

  • 1Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, Ontario M5G 1X8, Canada. shelly.weiss@sickkids.ca

Adolescent Medicine: State of the Art Reviews
|February 10, 2011
PubMed

Insights

Pediatric sleep disorders impact learning and behavior. Treatment, including behavioral interventions and pharmacotherapy, requires accurate diagnosis and understanding of limited research, especially for adolescents.

Area of Science:

  • Pediatric Sleep Medicine
  • Pharmacology
  • Child Psychology

Background:

  • Sleep disorders are common in children and adolescents, affecting daytime functioning like learning, memory, attention, and behavior.
  • Untreated sleep problems can lead to significant negative impacts on a child's development and daily life.

Purpose of the Study:

  • To outline the pharmacologic treatment of sleep disorders in typically developing children and adolescents.
  • To emphasize the importance of accurate diagnosis and understanding the role of pharmacotherapy.

Main Methods:

  • Review of current literature on pediatric sleep disorders and their treatment.
  • Discussion of the principles guiding pharmacotherapy and behavioral interventions.
  • Focus on pharmacologic approaches for various pediatric sleep conditions.

Main Results:

  • Behavioral interventions are effective for young children with insomnia, with less evidence for school-age children and adolescents.
  • Pharmacotherapy for pediatric insomnia is not well-defined, often relying on adult data and off-label use.
  • Specific sleep disorders beyond insomnia may warrant pharmacotherapy combined with behavioral strategies.

Conclusions:

  • Accurate diagnosis is crucial for effective treatment of pediatric sleep disorders.
  • Non-pharmacologic strategies are generally the first line of treatment, especially for insomnia.
  • Further research is needed on pharmacotherapy for sleep disorders in pediatric populations.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...